Tag: FreeStyle Libre 3
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
Abbott opens new facility for sensors, CGMs
November 18, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, Ireland, part of its €440 million investment in the country. The new 30,000-square-meter Kilkenny facility is producing FreeStyle Libre 3 sensors and the latest generation in Abbott’s continuous glucose monitoring portfolio for people living with diabetes. "This is our latest commitment to providing innovative care and supporting...
FDA clears readers for FreeStyle Libre 3
April 14, 2023HME News Staff
ABBOTT PARK, Ill. – Abbott has received clearance from the U.S. Food and Drug Administration (FDA) for a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system, which features a small, thin and discreet glucose sensor. With the FDA's clearance of a standalone reader, Abbott is working to get the FreeStyle Libre 3 system added to Medicare's list of covered systems as soon as possible. "Our customers all over the world consistently tell us how our FreeStyle...
Abbott receives FDA clearance for FreeStyle Libre 3
June 1, 2022HME News Staff
ABBOTT PARK, Ill. – Abbott has received clearance from the U.S. Food and Drug Administration for its FreeStyle Libre 3 system for people with diabetes age four and up. "The FreeStyle Libre 3 system is a direct result of listening to our customers – and giving them the innovation and sensing technology they've been looking for," said Jared Watkin, senior vice president of Abbott's diabetes care business. "It's a game changer for the millions of people living with diabetes....